Coronary CTA exposes plaque risk for diabetics
Findings from a large multicenter study suggest 64-slice CT angiography is better suited than other cardiac diagnostic tests for detecting clinically relevant coronary artery plaques in patients with diabetes.
Findings from a large multicenter study suggest 64-slice CT angiography is better suited than other cardiac diagnostic tests for detecting clinically relevant coronary artery plaques in patients with diabetes.
Dr. Fay Y. Lin, an associate professor of medicine at Cornell University, and colleagues prospectively evaluated a cohort of 3926 patients with symptomatic cardiovascular disease, Lin determined that 727 had diabetes. All patients underwent coronary 64-slice CTA between 2005 and 2007. Researchers found that patients with diabetes faced twice the risk of dying from a cardiac-related problem within two years of diagnosis as nondiabetic patients. CTA more accurately characterized plaque burden than alternative modalities for patients with low calcium score or normal stress testing results. Lin reported the findings at the 2009 Society of Cardiovascular Computed Tomography meeting.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
